ARID1A and keratoconus: Surprisingly, our “KAC” cells were both relatively resistant to cisplatin and PARP inhibitors (compared to the “KC” and “KPC” lines), and by the Comet assay, their DNA repair proficiency was comparable to these Arid1a wild type PDAC lines.